Russia has registered the drug Leitragin spray against Covid-19
Laitragin is the first drug that aims to prevent and fight the cytokine storm caused by Covid-19 in the body.
The Russian Ministry of Health has registered the drug "Leitragin" for the prevention and treatment of pneumonia caused by coronavirus infection, the Russian Agency for Medicine and Biology announced today through its website.
The spray drug Leitragin, developed by the Agency for Medicine and Biology, is registered with the Russian Ministry of Health. It is intended for the prevention and treatment of pneumonia. "The aim is to prevent pneumonia, which is one of the complications of the coronavirus," the agency's website said.
The statement added that the production of the drug is already underway.
Laitragin is the first drug that aims to prevent and fight the cytokine storm caused by Covid-19 in the body.
During the clinical trial, there were no deaths or serious cases among 320 patients with moderate symptoms of Covid-19.
Patients taking Leitragin recovered in an average of eight days, while patients treated with classical methods recovered in 14 days, according to clinical trials.